High mortality from Guillain-Barre syndrome in Bangladesh

被引:36
作者
Ishaque, Tanveen [1 ,2 ]
Islam, Mohammad B. [1 ,3 ]
Ara, Gulshan [1 ]
Endtz, Hubert P. [1 ,3 ,4 ]
Mohammad, Quazi D. [5 ]
Jacobs, Bart C. [6 ,7 ]
Islam, Zhahirul [1 ]
机构
[1] Int Ctr Diarrhoeal Dis Res Icddr B, Lab Sci & Serv Div, GPO Box 128, Dhaka 1000, Bangladesh
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[3] Erasmus Univ, Dept Med Microbiol & Infect Dis, Med Ctr, Rotterdam, Netherlands
[4] Fdn Merieux, Lyon, France
[5] Natl Inst Neurosci & Hosp, Dhaka, Bangladesh
[6] Erasmus Univ, Dept Neurol, Med Ctr, Rotterdam, Netherlands
[7] Erasmus Univ, Dept Immunol, Med Ctr, Rotterdam, Netherlands
关键词
autonomic dysfunction; Bangladesh; Guillain-Barre syndrome; mechanical ventilation; mortality; PREDICTORS; DIAGNOSIS; VALIDATION;
D O I
10.1111/jns.12215
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Although Guillain-Barre syndrome (GBS) has higher incidence and poor outcome in Bangladesh, mortality from GBS in Bangladesh has never been explored before. We sought to explore the frequency, timing, and risk factors for deaths from GBS in Bangladesh. We conducted a prospective study on 407 GBS patients who were admitted to Dhaka Medical College Hospital, Dhaka, Bangladesh from 2010 to 2013. We compared deceased and alive patients to identify risk factors. Cox regression model was used to adjust for confounders. Of the 407 GBS patients, 50 (12%) died, with the median time interval between the onset of weakness and death of 18 days. Among the fatal cases, 24 (48%) were 40 years, 36 (72%) had a Medical Research Council sum score 20 at entry, 33 (66%) had a progressive phase <8 days, and 27 (54%) required ventilation support. Ten patients (20%) died due to unavailability of ventilator. The strongest risk factor for deaths was lack of ventilator support when it was required (HR: 11.9; 95% confidence interval [CI]: 4.6-30.7). Other risk factors for death included age 40 years (HR: 5.9; 95% CI: 2.1-16.7), mechanical ventilation (HR: 2.3; 95% CI: 1.02-5.2), longer progressive phase (>8 days) (HR: 2.06; 95% CI: 1.1-3.8), autonomic dysfunction (HR: 1.9; 95% CI: 1.05-3.6), and bulbar nerve involvement (HR: 5.4; 95% CI: 1.5-19.2). In Bangladesh, GBS is associated with higher mortality rates, which is related to lack of ventilator support, disease severity, longer progressive phase of the disease, autonomic dysfunction, and involvement of the bulbar nerves.
引用
收藏
页码:121 / 126
页数:6
相关论文
共 32 条
[1]  
Aladro-Benito Y, 2002, REV NEUROLOGIA, V35, P705
[2]   Guillain-Barre syndrome - Incidence and mortality rates in US hospitals [J].
Alshekhlee, Amer ;
Hussain, Zulfiqar ;
Sultan, Badr ;
Katirji, Bashar .
NEUROLOGY, 2008, 70 (18) :1608-1613
[3]   ASSESSMENT OF CURRENT DIAGNOSTIC-CRITERIA FOR GUILLAIN-BARRE-SYNDROME [J].
ASBURY, AK ;
CORNBLATH, DR .
ANNALS OF NEUROLOGY, 1990, 27 :S21-S24
[4]   The morbidity and outcome of patients With Guillain-Barre syndrome admitted to the intensive care unit [J].
Dhar, Rajat ;
Stitt, Larry ;
Hahn, Angelika F. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2008, 264 (1-2) :121-128
[5]   Mortality associated with a diagnosis of Guillain-Barre syndrome in adults of Mexican health institutions [J].
Dominguez-Moreno, Rogelio ;
Tolosa-Tort, Paulina ;
Patino-Tamez, Anais ;
Quintero-Bauman, Alejandra ;
Collado-Frias, Deisy K. ;
Miranda-Rodriguez, Maria G. ;
Canela-Calderon, Obet J. ;
Hurtado-Valadez, Pablo ;
de Gante-Castro, Raul ;
Ortiz-Guillen, Karoll M. ;
Estanol-Vidal, Bruno ;
Senties-Madrid, Horacio ;
Garcia-Ramos, Guillermo ;
Cantu-Brito, Carlos ;
Luis Ruiz-Sandoval, Jose ;
Chiquete, Erwin .
REVISTA DE NEUROLOGIA, 2014, 58 (01) :4-10
[6]   Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria [J].
Fokke, Christiaan ;
van den Berg, Bianca ;
Drenthen, Judith ;
Walgaard, Christa ;
van Doorn, Pieter Antoon ;
Jacobs, Bart Casper .
BRAIN, 2014, 137 :33-43
[7]   Guillain-Barre Syndrome: Natural history and prognostic factors: a retrospective review of 106 cases [J].
Gonzalez-Suarez, Ines ;
Sanz-Gallego, Irene ;
Javier Rodriguez de Rivera, Francisco ;
Arpa, Javier .
BMC NEUROLOGY, 2013, 13
[8]   Preceding infections, immune factors, and outcome in Guillain-Barre syndrome [J].
Hadden, RDM ;
Karch, H ;
Hartung, HP ;
Zielasek, J ;
Weissbrich, B ;
Schubert, J ;
Weishaupt, A ;
Cornblath, DR ;
Swan, AV ;
Hughes, RAC ;
Toyka, KV .
NEUROLOGY, 2001, 56 (06) :758-765
[9]   CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHY [J].
HUGHES, RAC ;
NEWSOMDAVIS, JM ;
PERKIN, GD ;
PIERCE, JM .
LANCET, 1978, 2 (8093) :750-753
[10]   The Italian Guillain-Barre Study Group. The prognosis and main prognostic indicators of Guillain-Barre syndrome: A multicentre prospective study of 297 patients [J].
Hughes, RAC ;
Hadden, RDM ;
Rees, JH ;
Swan, AV .
BRAIN, 1998, 121 :767-768